312 related articles for article (PubMed ID: 15897568)
21. Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.
Signoretti S; Regan M; Atkins M
BJU Int; 2008 Jun; 101 Suppl 4():31-5. PubMed ID: 18430120
[No Abstract] [Full Text] [Related]
22. Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma.
Yang JS; Lin CW; Chuang CY; Su SC; Lin SH; Yang SF
Tumour Biol; 2015 Dec; 36(12):9517-24. PubMed ID: 26130414
[TBL] [Abstract][Full Text] [Related]
23. The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness.
Panelli MC; Wang E; Marincola FM
Clin Cancer Res; 2005 May; 11(10):3601-3. PubMed ID: 15897553
[No Abstract] [Full Text] [Related]
24. [Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression].
Rubio-Briones J; Calatrava A; Fernández-Serra A; Ramos Ruiz R; Iborra I; García-Casado Z; Rubio L; Trassierra M; Collado A; Casanova J; Gómez-Ferrer A; Solsona E; López-Guerrero JA
Actas Urol Esp; 2011 Feb; 35(2):80-6. PubMed ID: 21256634
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.
Choschzick M; Oosterwijk E; Müller V; Woelber L; Simon R; Moch H; Tennstedt P
Virchows Arch; 2011 Aug; 459(2):193-200. PubMed ID: 21691815
[TBL] [Abstract][Full Text] [Related]
27. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
[TBL] [Abstract][Full Text] [Related]
28. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.
Ingels A; Hew M; Algaba F; de Boer OJ; van Moorselaar RJ; Horenblas S; Zondervan P; de la Rosette JJ; Pilar Laguna Pes M
World J Urol; 2017 Jan; 35(1):81-87. PubMed ID: 27207480
[TBL] [Abstract][Full Text] [Related]
29. Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma.
Måseide K; Kandel RA; Bell RS; Catton CN; O'Sullivan B; Wunder JS; Pintilie M; Hedley D; Hill RP
Clin Cancer Res; 2004 Jul; 10(13):4464-71. PubMed ID: 15240538
[TBL] [Abstract][Full Text] [Related]
30. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies.
Al-Ahmadie HA; Alden D; Qin LX; Olgac S; Fine SW; Gopalan A; Russo P; Motzer RJ; Reuter VE; Tickoo SK
Am J Surg Pathol; 2008 Mar; 32(3):377-82. PubMed ID: 18300814
[TBL] [Abstract][Full Text] [Related]
31. Serum carbonic anhydrase IX during first-line therapy of ovarian cancer.
Woelber L; Mueller V; Eulenburg C; Schwarz J; Carney W; Jaenicke F; Milde-Langosch K; Mahner S
Gynecol Oncol; 2010 May; 117(2):183-8. PubMed ID: 20051287
[TBL] [Abstract][Full Text] [Related]
32. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
33. [MN/CAIX gene expression in renal cell carcinoma detected by RT-PCR].
Jiang YD; Zheng SB; Wang ZH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):925-7. PubMed ID: 15321764
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.
Peña C; Lathia C; Shan M; Escudier B; Bukowski RM
Clin Cancer Res; 2010 Oct; 16(19):4853-63. PubMed ID: 20651059
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial.
Chamie K; Klöpfer P; Bevan P; Störkel S; Said J; Fall B; Belldegrun AS; Pantuck AJ
Urol Oncol; 2015 May; 33(5):204.e25-33. PubMed ID: 25823535
[TBL] [Abstract][Full Text] [Related]
36. Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma.
Ameis HM; Drenckhan A; Freytag M; Izbicki JR; Supuran CT; Reinshagen K; Holland-Cunz S; Gros SJ
J Enzyme Inhib Med Chem; 2016; 31(3):404-9. PubMed ID: 25884234
[TBL] [Abstract][Full Text] [Related]
37. High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma.
Brockton NT; Klimowicz AC; Bose P; Petrillo SK; Konno M; Rudmik L; Dean M; Nakoneshny SC; Matthews TW; Chandarana S; Lau HY; Magliocco AM; Dort JC
Oral Oncol; 2012 Jul; 48(7):615-22. PubMed ID: 22366443
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma.
Jensen HK; Nordsmark M; Donskov F; Marcussen N; von der Maase H
BJU Int; 2008 Jun; 101 Suppl 4():41-4. PubMed ID: 18430123
[No Abstract] [Full Text] [Related]
39. Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma.
Patard JJ; Fergelot P; Karakiewicz PI; Klatte T; Trinh QD; Rioux-Leclercq N; Said JW; Belldegrun AS; Pantuck AJ
Int J Cancer; 2008 Jul; 123(2):395-400. PubMed ID: 18464292
[TBL] [Abstract][Full Text] [Related]
40. Expression of carbonic anhydrase IX in genitourinary and adrenal tumours.
Donato DP; Johnson MT; Yang XJ; Zynger DL
Histopathology; 2011 Dec; 59(6):1229-39. PubMed ID: 22175902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
